Desmopressin Injection Shortage

• • DDAVP injection, Ferring, 4 mcg/mL, 1 mL ampule, 10 count, NDC 00075-2451-01
  • DDAVP injection, Ferring, 4 mcg/mL, 10 mL multiple dose vial, 1 count, NDC 00075-2451-53
  • Desmopressin Acetate injection, Caraco, 4 mcg/mL, 10 mL multiple dose vial, 1 count, NDC 62756-0529-40
  • Desmopressin Acetate injection, Ferring, 4 mcg/mL, 1 mL ampule, 10 count, NDC 55566-5030-01
  • Desmopressin Acetate injection, Ferring, 4 mcg/mL, 10 mL multiple dose vial, 1 count, NDC 55566-5040-01
  • Desmopressin Acetate injection, Pfizer, 4 mcg/mL, 1 mL ampule, 10 count, NDC 00409-2265-01
  • Desmopressin Acetate injection, Teva, 4 mcg/mL, 1 mL vial, 10 count, NDC 00703-5051-03
  • Desmopressin Acetate injection, Teva, 4 mcg/mL, 10 mL multiple dose vial, 1 count, NDC 00703-5054-01

• • Teva and Hospira have desmopressin injection on shortage due to manufacturing delays.
  • Ferring divested generic desmopressin to Amring Pharmaceuticals in January 2016.
  • Caraco will not provide availability information at this time.

• • DDAVP injection, Ferring, 4 mcg/mL, 1 mL ampule, 10 count, NDC 55566-2200-00
  • DDAVP injection, Ferring, 4 mcg/mL, 10 mL multiple dose vial, 1 count, NDC 55566-2300-00
  • Desmopressin Acetate injection, Amring Pharmaceuticals, 4 mcg/mL, 1 mL ampule, 10 count, NDC 69918-0899-10
  • Desmopressin Acetate injection, Amring Pharmaceuticals, 4 mcg/mL, 10 mL vial, 1 count, NDC 69918-0901-10

Estimated Resupply Dates

• • Hospira has desmopressin 4 mcg/mL 1 mL ampules on back order and the company cannot estimate a release date.
  • Teva has desmopressin 4 mcg/mL 1 mL and 10 mL vials on long-term back order and the company estimates a release date in fourth quarter of 2017.
  • Amring and Ferring have had product available for several months and have been supplying the market.